LATEST UPDATES » Vol 24, No. 09, September 2020 – 3D Technology: Additive Manufacturing Applications and Prospects       » Results of CD30 CAR-T Cell Therapy Trial Shows Promise for Hodgkin Lymphoma Patients       » Emerging Technologies and Innovations amid a Global Pandemic       » Monitoring COVID-19 Patients with AI-powered Platform       » Singapore Researchers Devise a Rapid COVID-19 Test Kit for the Detection of Neutralising Antibodies (NAbs) Against SARS-CoV-2       » Novel Ventilator Conceptualized by Singapore Clinicians Provides Efficient and Personalized Breathing Support for COVID-19 patients      
Vol 24, No. 09, September 2020   |   Issue PDF view/purchase
Boosting Innovation in the Field of Urology
Dornier MedTech launches UroX, a community that connects professionals from various disciplines to cultivate innovation and solve the most pressing challenges in urology.

Globally, over 900 million people suffer from urological disorders, together with the challenges urological patients face in managing their disease. To drive innovation in urological treatment, Dornier launched UroX to connect talents, technologies, and funding to solve critical problems facing urology today. Two new initiatives will be rolled out for the UroX community: The UroXChallenge and UroXChange.

Wong Yau Chung, Chief Operating Officer at Dornier MedTech said, “UroX community aims to facilitate and accelerate innovations in urology by connecting innovators of various background and the resources they need to succeed. We are glad to have the support of local incubators and like-minded organizations, and hope to ultimately bring more creative treatment options to benefit patients and physicians.”

Developing innovative treatment options would require the collaboration between key stakeholders including clinicians, corporations, academics, researchers, government and private funding organizations, engineers, and entrepreneurs.

The UroXChallenge is Asia’s largest medtech call for innovations in urology, where up to SGD$500k of funding will be offered to innovative proposals with the potential to make a breakthrough in urological patient care and treatment. Areas of interest include kidney stones, urological cancers, urinary incontinence, medical devices, digital solutions and precision medicine. Throughout the challenge, technical, clinical as well as commercial mentorship will be provided to the participants, to help them bring their innovations closer to market.

The UroXChallenge is organized in collaboration with A*ccelerate, the commercialization arm of the Agency for Science, Technology and Research (A*STAR), National Health Innovation Centre Singapore (NHIC), a provider of translational funding and strategic guidance to publicly-funded clinical research, and Advanced MedTech, a global medical technology leader with a core focus in urology devices and services.

Dornier is also organizing UroXChange, a series of webinars and events that aim to provide the UroX community the knowledge and expertise from renowned opinion leaders in urology space, including academics and clinicians.

The inaugural webinar held on 6th August 2020, leading urology clinicians in Singapore will share their experiences and urgent needs for innovation in urology and invite people of distinct expertise and background to take up the challenge to solve unmet needs in the industry.


news PharmaSources Launches the Export-Driven Event CPhI & P-MEC China E-Trade Season
news PharmaSources.com to Help Propel the Chinese API Export Business with E-Trade Session CPhI China Top API Exporters & Products
news Singapore Biomedical Company Appointed as a Certified Service Provider by 10x Genomics
news Proteona Honoured with "one to watch" Prize in the Inaugural Spinoff Prize by Nature Research and Merck Grou

About Us
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
Copyright© 2020 World Scientific Publishing Co Pte Ltd  •  Privacy Policy